161
Participants
Start Date
November 21, 2014
Primary Completion Date
December 29, 2017
Study Completion Date
December 29, 2017
Ruxolitinib
supplied as 5 mg, 10 mg and 20 mg tablets to be taken orally
Novartis Investigative Site, Brussels
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Leuven
Novartis Investigative Site, Liège
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Yvoir
Novartis Investigative Site, Pleven
Novartis Investigative Site, Bruges
Novartis Investigative Site, Tromsø
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Marseille
Novartis Investigative Site, Berlin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Bottrop
Novartis Investigative Site, Angers
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Vandœuvre-lès-Nancy
Novartis Investigative Site, Koblenz
Novartis Investigative Site, Metz
Novartis Investigative Site, Hamm
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Aschaffenburg
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Bayonne
Novartis Investigative Site, Bad Soden
Novartis Investigative Site, Perpignan
Novartis Investigative Site, Mulhouse
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Le Mans
Novartis Investigative Site, Chambéry
Novartis Investigative Site, Mutlangen
Novartis Investigative Site, Heilbronn
Novartis Investigative Site, Pringy
Novartis Investigative Site, Paris
Novartis Investigative Site, Meaux
Novartis Investigative Site, Avignon
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Friedrichshafen
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Eisenach
Novartis Investigative Site, Viña del Mar
Novartis Investigative Site, Santiago
Novartis Investigative Site, Linz
Novartis Investigative Site, Wels
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Santiago
Novartis Investigative Site, Nice
Novartis Investigative Site, Fredrikstad
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Luleå
Novartis Investigative Site, Uddevalla
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY